"Designing Growth Strategies is in our DNA"

Hemato Oncology Testing Market Size, Share & Industry Analysis, By Products & Services (Assay Kits & Reagents, Services, and Instruments & Platforms), By Cancer Type (Leukemia, Lymphoma, Multiple Myeloma, and Others), By Testing Technology (Flow Cytometry, Fluorescence in Situ Hybridization, Molecular Diagnostics {PCR, NGS, and Others}, Immunohistochemistry, and Others), By End-user (Academic & Research Institutes, Hospitals & Diagnostic Laboratories, and Others), and Regional Forecast, 2026-2034

Last Updated: January 22, 2026 | Format: PDF | Report ID: FBI115278

 


To get information on various segments, share your queries with us

ATTRIBUTE

DETAILS

Study Period

2021-2034

Base Year

2025

Estimated Year

2026

Forecast Period

2026-2034

Historical Period

2021-2024

Growth Rate

CAGR of 7.2% from 2026-2034

Unit

Value (USD Billion)

Segmentation

By Products & Services, Cancer Type, Testing Technology, End-User, and Region

By    Products & Services

·         Assay Kits & Reagents

·         Services

·         Instruments & Platforms

By Cancer Type

·         Leukemia

·         Lymphoma

·         Multiple Myeloma

·         Others

By Testing Technology

·         Flow Cytometry

·         Fluorescence in situ hybridization

·         Molecular Diagnostics

o   PCR

o   NGS

o   Others

·         Immunohistochemistry

·         Others

By End-User

·         Academic & Research Institutes

·         Hospitals & Diagnostic Laboratories

·         Others

By Region

·         North America (By Products & Services, Cancer Type, Testing Technology, End-User, and Country)

o   U.S.

§  Products & Services

o   Canada

§  Products & Services

·         Europe (By Products & Services, Cancer Type, Testing Technology, End-User, and Country/Sub-region)

o   Germany

§  Products & Services

o   U.K.

§  Products & Services

o   France

§  Products & Services

o   Spain

§  Products & Services

o   Italy

§  Products & Services

o   Scandinavia

§  Products & Services

o   Rest of Europe

§  Products & Services

·         Asia Pacific (By Products & Services, Cancer Type, Testing Technology, End-User, and Country/Sub-region)

o   China

§  Products & Services

o   Japan

§  Products & Services

o   India

§  Products & Services

o   Australia

§  Products & Services

o   Southeast Asia

§  Products & Services

o   Rest of Asia Pacific

§  Products & Services

·         Latin America (By Products & Services, Cancer Type, Testing Technology, End-User, and Country/Sub-region)

o   Brazil

§  Products & Services

o   Mexico

§  Products & Services

o   Rest of Latin America

§  Products & Services

·         Middle East & Africa (By Products & Services, Cancer Type, Testing Technology, End-User, and Country/Sub-region)

o   GCC

§  Products & Services

o   South Africa

§  Products & Services

o   Rest of the Middle East & Africa

§  Products & Services

  • 2021-2034
  • 2025
  • 2021-2024
  • 120
Download Free Sample

    man icon
    Mail icon
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann